Clinical Trial Update: Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of intravenous AMBTX-01 (neridronate) for complex regional pain syndrome type I is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complex Regional Pain Syndrome Type

Drugs mentioned

• AMBTX-01 (neridronate)

Snippet

Sponsor: Ambros Therapeutics, Inc. | Conditions: Complex Regional Pain Syndrome Type I | Phase 3 | Status: RECRUITING